Company
Last deal
$5.4M
Local Amount - EUR 5M
Amount
Series A
Stage
14.06.2024
Date
2
all rounds
$9.9M
Total amount
General
About Company
ElmediX develops semi-automated hyperthermal therapy system to improve pancreatic cancer treatment.
Industry
Sector :
Subsector :
founded date
01.01.2015
Number of employees
Company Type
For Profit
Last funding type
Series A
IPO status
Private